Dr. Angel Simeonov Galabov

Professor
Bulgarian Academy of Science, Bulgaria

Highest Degree
PostDoc Fellow in Virology from Pasteur Institute, France

My URL
https://livedna.org/359.20377

Share this Profile

Area of Interest:

Biomedical Sciences
Infectious Disease
Chemotherapy
Histology
Cytology

Selected Publications

  1. Galabov, A.S., V. Vassileva and V. Karabasheva, 2017. Inhibitory effect of abitylguanide on adenovirus replication. Drug Res., 67: 583-590.
    CrossRef  |  Direct Link  |  

  2. Galabov, A.S., L. Mukova, Y.P. Abashev, L. Wassilewa and P. Tzvetkov et al., 2017. Cycluridine: A novel antiviral effective against flaviviruses. Antiviral Chem. Chemother., 25: 58-67.
    CrossRef  |  Direct Link  |  

  3. Arita, M., G. Dobrikov, G. Purstinger and A. Galabov, 2017. Allosteric regulation of phosphatidylinositol 4-kinase III beta by an anti-picornavirus compound MDL-860. ACS Infect. Dis., 3: 585-594.
    CrossRef  |  Direct Link  |  

  4. Angelova, A.L., M. Witzens-Harig, A.S. Galabov and J. Rommelaere, 2017. The oncolytic virotherapy era in cancer management: Prospects of applying H-1 parvovirus to treat blood and solid cancers. Front. Oncol., Vol. 7. 10.3389/fonc.2017.00093.
    CrossRef  |  Direct Link  |  

  5. Vassileva-Pencheva, R. and A.S. Galabov, 2016. Effectiveness of the consecutive alternating administration course of a triple antiviral combination in coxsackievirus B3 infections in mice. Drug Res., 66: 639-643.

  6. Galabov, A.S., 2016. Role of Viruses in the Etiology and Pathogenesis. In: Balkan Endemic Nephropathy: A Comprehensive View, Stefanovic, V. (Ed.). Press Product Line, Sofia, Bulgaria, pp: 105-130.

  7. Galabov, A.S. and A. Pashov, 2016. Immunologic Mechanisms. In: Balkan Endemic Nephropathy: A Comprehensive View, Stefanovic, V. (Ed.). Press Product Line, Sofia, Bulgaria, pp: 131-140.

  8. Stoyanova, A., I. Nikolova, G. Purstinger, G. Dobrikov, V. Dimitrov, S. Philipov and A.S. Galabov, 2015. Anti-enteroviral triple combination of viral replication inhibitors: Activity against coxsackievirus B1 neuroinfection in mice. Antiviral Chem. Chemother., 24: 136-147.
    CrossRef  |  Direct Link  |  

  9. Galabov, A.S., M. Mileva, L. Simeonova and G. Gegova, 2015. Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice. Antiviral Chem. Chemother., 24: 83-91.
    CrossRef  |  Direct Link  |  

  10. Vassileva-Pencheva, R. and A.S. Galabov, 2010. Avoiding drug-resistance development by novel approach of combining anti-enteroviral substances against coxsackievirus B1 infection in mice. Antiviral Res., 85: 366-372.
    CrossRef  |  Direct Link  |  

  11. Raykov, Z., P.B. Georgieva, A. Angelova, A.S. Galabov and J. Rommelaere, 2009. Anticancer effects of an oncolytic parvovirus combined with non-conventional therapeutics on pancreatic carcinoma cell lines. Acta Virol., 53: 57-60.
    PubMed  |  

  12. Angelova, A.L., M. Aprahamian, G. Balboni, H.J. Delecluse and R. Feederle et al., 2009. Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies. Mol. Therapy, 17: 1164-1172.
    CrossRef  |  Direct Link  |  

  13. Nikolaeva-Glomb, L., S. Philipov and A.S. Galabov, 2008. A New Highly Potent Antienteroviral Compound. In: National Institute of Allergy and Infectious Diseases, Volume 1 Frontiers in Research, St. Georgiev, V., K.A. Western and J.J. McGowan (Eds.). Humana Press, Totowa, NJ., pp: 199-202.

  14. Raykov, Z., S. Grekova, A.S. Galabov, G. Balboni, U. Koch, M. Aprahamian and J. Rommelaere, 2007. Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model. Oncol. Rep., 17: 1493-1499.
    CrossRef  |  Direct Link  |  

  15. Kramer, A., A.S. Galabov, S.A. Sattar, L. Dohner and A. Pivert et al., 2006. Virucidal activity of a new hand disinfectant with reduced ethanol content: comparison with other alcohol-based formulations. J. Hosp. Infect., 62: 98-106.
    CrossRef  |  Direct Link  |  

  16. Galabov, A.S., L. Simeonova and G. Gegova, 2006. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice. Antiviral Chem. Chemother., 17: 251-258.
    CrossRef  |  Direct Link  |  

  17. Galabov, A.S. and A. Angelova, 2006. Antiviral agents in the prevention and treatment of virus-induced diabetes. Anti-Infective Agents Med. Chem., 5: 293-307.
    CrossRef  |  Direct Link  |  

  18. Nikolaeva-Glomb, L., and A.S. Galabov, 2004. Synergistic combinations against the replication in vitro of Coxsackievirus B1. Antiviral Res., 62: 9-19.

  19. Toncheva, D., A.S. Galabov, A. Laich, S. Atanassova, B. Kamarinchev, T. Dimitrov and D. Fuchs, 2003. Urinary neopterin concentrations in patients with Balkan endemic nephropathy (BEN). Kidney Int., 64: 1817-1821.
    CrossRef  |  Direct Link  |  

  20. Nikolova, I. and A.S. Galabov, 2003. Development of resistance to disoxaril in Coxsackievirus B1 infected newborn mice. Antiviral Res., 60: 35-40.

  21. Mileva, M., R. Bakalova, L. Tancheva and A. Galabov, 2002. Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice. Arch. Toxicol., 76: 96-103.
    CrossRef  |  Direct Link  |  

  22. Mileva, M., L. Tancheva, R. Bakalova, A. Galabov, V. Savov and S. Ribarov, 2000. Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection. Toxicol. Lett., 114: 39-45.
    CrossRef  |  Direct Link  |  

  23. Wassilewa, L., S. Uzunov, A.S. Galabov, A.N. Simonov, S. Markushin and M. Alexandrov, 1995. Characterization of the virions of mopyridone-sensitive wild strain and mopyridone-resistant mutant of influenza virus A (H3N2). Acta Virol., 39: 79-84.
    PubMed  |  

  24. Vassileva, P. and A.S. Galabov, 1993. Combined Therapy of Epidemic Keratoconjunctivitis. In: Update of Infectious Diseases of the Eye, Bialasiewicz, A. (Ed.). Springer, New York, pp: 307-314.

  25. Jablenska, R., G. Gerganov, S. Donev and A. Galabov, 1992. Replication of the pseudorabies virus in cultured pancreatic islet cells: Further evidence of their paraneuronal nature. Arch. Histol. Cytol., 55: 491-496.
    CrossRef  |  Direct Link  |  

  26. Konstantinov, K., A. Galabov and M. Mastikova, 1989. Interferon response to dipyridamole in lupus erythematosus patients. Br. J. Dermatol., 121: 59-63.
    CrossRef  |  Direct Link  |  

  27. Galabov, A.S., A.V. Itkes, M. Mastikova, V.L. Tunitskaya and E.S. Severin, 1985. Dipyridamole-induced interferon production in mouse peritoneal leukocytes. Biochem. Int., 11: 591-598.
    PubMed  |  

  28. Galabov, A.S., 1981. Induction and Characterization of Tortoise Interferon. In: Interferons/Methods in Enzymology, Pestka, S. (Ed.). Academic Press, New York, pp: 196-208.

  29. Galabov, A.S., B.S. Galabov and N.A. Neykova, 1980. Structure-activity relationship of diphenylthiourea antivirals. J. Med. Chem., 23: 1048-1051.
    CrossRef  |  PubMed  |  

  30. Galabov, A.S., 1973. Interferonogenesis and phylogenesis. Bull. Inst. Pasteur, 71: 233-247.
Member since October, 2017